LON:GSK - GlaxoSmithKline Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
GBX 1,556.40 -7.40 (-0.47 %)
(As of 07/19/2018 10:43 AM ET)
Previous CloseGBX 1,563.80
Today's RangeGBX 1,554.60 - GBX 1,565.20
52-Week RangeGBX 1,235.20 - GBX 1,724.50
Volume5.69 million shs
Average Volume9.12 million shs
Market Capitalization£65.63 billion
P/E RatioN/A
Dividend YieldN/A
BetaN/A
GlaxoSmithKline logoGlaxoSmithKline plc engages in the creation, discovery, development, manufacture, and marketing of vaccines, over-the-counter medicines, and health-related consumer products worldwide. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory, anti-virals, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterials, dermatology, rare diseases, immuno-inflammation, and HIV, as well as vaccines. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health categories primarily under the Otrivin, Panadol, Fenistil, Lamisil, Breathe Right, Stiefel, Excedrin, Physiogel, Polident, parodontax, Poligrip, Sensodyne, Theraflu, and Voltaren brand names. The company offers its consumer healthcare products in the form of tablets, caplets, infant syrup drops, syrups, topical gels, nasal sprays, effervescents, lozenges, gum and trans-dermal patches, malted drinks and foods, and topical creams and non-medicated patches, as well as toothpastes, toothbrushes, mouth rinses, medicated mouthwashes, gels and sprays, denture adhesives, and denture cleansers. It has a discovery collaboration agreement with Kymera Therapeutics LLC; and a collaboration agreement with InSysBio LLC to develop quantitative systems pharmacology model of asthma. GlaxoSmithKline plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.

Receive GSK News and Ratings via Email

Sign-up to receive the latest news and ratings for GSK and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange LON
Industry Drug Manufacturers - Major
Sub-IndustryN/A
SectorMedical
SymbolLON:GSK
CUSIPN/A
Phone+44-20-80475000

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins9.36%
Return on Equity348.10%
Return on Assets4.98%

Miscellaneous

EmployeesN/A
Outstanding Shares4,920,000,000
Market Cap£65,630.00

The Truth About Cryptocurrencies

GlaxoSmithKline (LON:GSK) Frequently Asked Questions

What is GlaxoSmithKline's stock symbol?

GlaxoSmithKline trades on the London Stock Exchange (LON) under the ticker symbol "GSK."

How often does GlaxoSmithKline pay dividends? What is the dividend yield for GlaxoSmithKline?

GlaxoSmithKline announced a dividend on Wednesday, April 25th. Stockholders of record on Thursday, May 10th will be paid a dividend of GBX 19 per share on Thursday, July 12th. This represents a dividend yield of 1.35%. The ex-dividend date of this dividend is Thursday, May 10th. The official announcement can be seen at this link. View GlaxoSmithKline's Dividend History.

How were GlaxoSmithKline's earnings last quarter?

GlaxoSmithKline plc (LON:GSK) announced its quarterly earnings results on Wednesday, April, 25th. The company reported $24.60 earnings per share (EPS) for the quarter, beating the consensus estimate of $24.30 by $0.30. GlaxoSmithKline had a net margin of 9.36% and a return on equity of 348.10%. View GlaxoSmithKline's Earnings History.

What price target have analysts set for GSK?

22 Wall Street analysts have issued 1-year price objectives for GlaxoSmithKline's stock. Their predictions range from GBX 1,130 to GBX 2,030. On average, they expect GlaxoSmithKline's share price to reach GBX 1,579.76 in the next twelve months. This suggests a possible upside of 1.5% from the stock's current price. View Analyst Ratings for GlaxoSmithKline.

What is the consensus analysts' recommendation for GlaxoSmithKline?

22 Wall Street analysts have issued "buy," "hold," and "sell" ratings for GlaxoSmithKline in the last year. There are currently 1 sell rating, 13 hold ratings and 8 buy ratings for the stock, resulting in a consensus recommendation of "Hold."

Who are some of GlaxoSmithKline's key competitors?

Who are GlaxoSmithKline's key executives?

GlaxoSmithKline's management team includes the folowing people:
  • Ms. Emma Walmsley, CEO & Director (Age 48)
  • Mr. Simon P. Dingemans, CFO & Exec. Director (Age 54)
  • Mr. Jack Bailey, Pres of US Pharmaceuticals
  • Ms. Karenann K. Terrell, Chief Digital & Technology Officer (Age 57)
  • Dr. Hal V. Barron, Chief Scientific Officer, Pres of R&D and Director (Age 55)

Has GlaxoSmithKline been receiving favorable news coverage?

News coverage about GSK stock has trended somewhat positive recently, according to Accern Sentiment. The research group rates the sentiment of media coverage by reviewing more than 20 million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. GlaxoSmithKline earned a daily sentiment score of 0.06 on Accern's scale. They also gave news coverage about the company an impact score of 45.67 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock's share price in the next few days.

How do I buy shares of GlaxoSmithKline?

Shares of GSK and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is GlaxoSmithKline's stock price today?

One share of GSK stock can currently be purchased for approximately GBX 1,556.40.

How big of a company is GlaxoSmithKline?

GlaxoSmithKline has a market capitalization of £65.63 billion.

How can I contact GlaxoSmithKline?

GlaxoSmithKline's mailing address is 980 Great West Road, BRENTFORD, TW8 9GS, United Kingdom. The company can be reached via phone at +44-20-80475000.


MarketBeat Community Rating for GlaxoSmithKline (LON GSK)

Community Ranking:  1.8 out of 5 (star)
Outperform Votes:  719 (Vote Outperform)
Underperform Votes:  1,326 (Vote Underperform)
Total Votes:  2,045
MarketBeat's community ratings are surveys of what our community members think about GlaxoSmithKline and other stocks. Vote "Outperform" if you believe GSK will outperform the S&P 500 over the long term. Vote "Underperform" if you believe GSK will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 7/19/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.